TR
Third Rock Ventures IV, L.P.
Other
内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Third Rock Ventures IV, L.P.. Director active across 3 companies, notably Magenta Therapeutics, Inc.. In total, 22 reports have been published. Split: 0 buy · 19 sells. Total volume traded: €42.4m. History available since 7 February 2023. The latest transaction was disclosed on 23 October 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Third Rock Ventures IV, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报22 总计
1,600,000 股Common StockSEC:0001193125-25-266981:0
477,401 股@ US$10.15210.2% 占其流量Common StockSEC:0001193125-25-251606:0
500,000 股@ US$8.0179.4% 占其流量Common StockSEC:0001193125-25-223227:0
363,541 股@ US$7.046.5% 占其流量Common StockSEC:0001193125-25-206453:0
642,906 股@ US$7.0012.5% 占其流量Common StockSEC:0001193125-25-199177:0
302,194 股@ US$7.006.7% 占其流量Common StockSEC:0000950170-25-111457:0
1,100,000 股@ US$7.011624.4% 占其流量Common StockSEC:0000950170-25-110662:0
5,762,788 股0Common StockSEC:0000950170-25-013760:0
67,400 股@ US$10.53053.4% 占其流量Common StockSEC:0000950170-24-107330:0
75,000 股@ US$11.56184.2% 占其流量Common StockSEC:0000950170-24-104863:0
175,000 股@ US$11.59839.8% 占其流量Common StockSEC:0000950170-24-103661:0
25,000 股@ US$11.54661.4% 占其流量Common StockSEC:0000950170-24-101910:0
135,000 股@ US$9.78856.5% 占其流量Common StockSEC:0000950170-24-099253:0
95,000 股@ US$9.80124.6% 占其流量Common StockSEC:0000950170-24-089474:0
50,000 股@ US$9.8392.4% 占其流量Common StockSEC:0000950170-24-087862:0
200,000 股@ US$9.81589.7% 占其流量Common StockSEC:0000950170-24-086894:0
262,740 股@ US$9.781912.6% 占其流量Common StockSEC:0000950170-24-086051:0
191,490 股@ US$9.80989.2% 占其流量Common StockSEC:0000950170-24-085256:0
550,171 股@ US$9.790326.4% 占其流量Common StockSEC:0000950170-24-084580:0
162,500 股@ US$12.009.7% 占其流量Common StockSEC:0000950170-24-018198:0
2,200,000 股@ US$0.83100.0% 占其流量Common StockSEC:0000899243-23-004411:0
1,250,000 股Common StockSEC:0000899243-21-034297:0
About Third Rock Ventures IV, L.P.
Third Rock Ventures IV, L.P. is a declarant linked to Tango Therapeutics, Inc., Maze Therapeutics, Inc. and Magenta Therapeutics, Inc. It has filed 22 filings in total, and among the recent filings tracked, they are all sales, for 42430088 EUR between 2021-08-26 and 2025-11-05.